Although SOCS5 dysregulation has been recently associated with acute and chronic lymphocytic leukemia (Toniolo et al., 2016; Sharma et al., 2019), its role in CML has not been characterized to date. Here, SOCS5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.